See more : Aridis Pharmaceuticals, Inc. (ARDS) Income Statement Analysis – Financial Results
Complete financial analysis of Tokyo Tatemono Co., Ltd. (8804.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Tokyo Tatemono Co., Ltd., a leading company in the Real Estate – Services industry within the Real Estate sector.
- Oriental Trimex Limited (ORIENTALTL.BO) Income Statement Analysis – Financial Results
- Zentalis Pharmaceuticals, Inc. (ZNTL) Income Statement Analysis – Financial Results
- Maiden Holdings North America, Ltd. (MHNC) Income Statement Analysis – Financial Results
- Chongqing Pharscin Pharmaceutical Co., Ltd. (002907.SZ) Income Statement Analysis – Financial Results
- PT Jasa Armada Indonesia Tbk (IPCM.JK) Income Statement Analysis – Financial Results
Tokyo Tatemono Co., Ltd. (8804.T)
About Tokyo Tatemono Co., Ltd.
Tokyo Tatemono Co., Ltd. operates as a real estate company in Japan. It operates through Building Business, Housing Business, Asset Service Business, Overseas Business, and Other Business segments. The company develops, leases, and operates office buildings, commercial facilities, logistics and warehouse facilities, condominiums, detached houses, etc. It also provides real estate sales, brokerage, consulting, asset management, and real estate appraisal services; and develops, manages, and operates child-care facilities and parking lots. In addition, it operates hotels, resort facilities, super public baths, and golf courses. The company was incorporated in 1896 and is headquartered in Tokyo, Japan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 375.95B | 349.94B | 340.48B | 334.98B | 323.04B | 273.30B | 266.98B | 254.50B | 260.01B | 237.05B | 220.03B | 194.16B | 166.94B | 198.27B | 262.61B | 199.81B | 213.22B | 234.34B | 176.47B | 161.30B |
| Cost of Revenue | 266.83B | 248.45B | 247.93B | 251.95B | 233.34B | 192.13B | 189.10B | 190.43B | 197.34B | 180.70B | 166.03B | 140.39B | 145.24B | 151.11B | 201.78B | 136.70B | 136.09B | 170.05B | 124.26B | 121.21B |
| Gross Profit | 109.12B | 101.49B | 92.54B | 83.03B | 89.69B | 81.17B | 77.89B | 64.07B | 62.68B | 56.35B | 54.00B | 53.78B | 21.71B | 47.16B | 60.83B | 63.11B | 77.12B | 64.29B | 52.21B | 40.09B |
| Gross Profit Ratio | 29.02% | 29.00% | 27.18% | 24.79% | 27.77% | 29.70% | 29.17% | 25.17% | 24.11% | 23.77% | 24.54% | 27.70% | 13.00% | 23.79% | 23.16% | 31.59% | 36.17% | 27.44% | 29.59% | 24.85% |
| Research & Development | 0.00 | 0.18 | 0.17 | 0.14 | 0.14 | 0.15 | 0.13 | 0.13 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 31.33B | 29.16B | 26.86B | 30.38B | 33.43B | -3.37B | -3.51B | -2.55B | 25.23B | 23.13B | 21.14B | 19.64B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 22.74B | 16.54B |
| Selling & Marketing | 3.70B | 3.68B | 3.17B | 3.01B | 3.85B | 3.38B | 3.51B | 2.55B | 3.01B | 2.67B | 3.49B | 3.25B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 35.04B | 32.84B | 30.02B | 33.39B | 37.28B | 0.10 | 0.08 | 0.08 | 28.24B | 25.79B | 24.63B | 22.88B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 22.74B | 16.54B |
| Other Expenses | 3.57B | 37.01B | 33.76B | 33.39B | 37.28B | 178.00M | -340.00M | 272.00M | 159.00M | 368.00M | 466.00M | -727.00M | -1.90B | -1.88B | -1.47B | 105.00M | 459.00M | 1.16B | 520.00M | 619.00M |
| Operating Expenses | 38.61B | 37.01B | 33.76B | 33.39B | 37.28B | 34.40B | 33.13B | 27.70B | 28.24B | 25.79B | 24.63B | 22.88B | 22.38B | 23.11B | 31.67B | 35.40B | 31.70B | 29.83B | 22.74B | 16.54B |
| Cost & Expenses | 305.44B | 285.46B | 281.69B | 285.35B | 270.63B | 226.54B | 222.23B | 218.13B | 225.57B | 206.49B | 190.66B | 163.27B | 167.62B | 174.22B | 233.45B | 172.10B | 167.79B | 199.88B | 147.00B | 137.75B |
| Interest Income | 251.00M | 28.00M | 21.00M | 18.00M | 35.00M | 8.00M | 40.00M | 5.00M | 12.00M | 18.00M | 28.00M | 41.00M | 37.00M | 44.00M | 27.00M | 35.00M | 35.00M | 87.00M | 126.00M | 95.00M |
| Interest Expense | 7.26B | 6.09B | 6.67B | 6.73B | 6.97B | 6.02B | 6.10B | 7.35B | 8.85B | 11.99B | 7.69B | 8.47B | 8.40B | 8.72B | 8.53B | 7.59B | 6.21B | 4.65B | 5.46B | 6.48B |
| Depreciation & Amortization | 20.69B | 285.46B | 281.72B | 285.35B | 279.48B | 233.92B | 230.27B | 226.93B | 15.93B | 15.15B | 8.61B | 9.04B | 9.27B | 8.39B | 8.67B | 6.69B | 4.83B | 4.22B | 3.74B | 3.32B |
| EBITDA | 91.20B | 83.59B | 77.65B | 69.25B | 71.34B | 64.92B | 61.43B | 52.27B | 50.37B | 45.71B | 37.97B | 39.94B | -58.22B | 32.44B | 37.83B | 34.40B | 50.30B | 40.52B | 33.65B | 27.75B |
| EBITDA Ratio | 24.26% | 25.36% | 21.09% | 21.92% | 21.83% | 24.23% | 23.28% | 21.18% | 19.07% | 18.44% | 17.65% | 19.87% | 4.07% | 15.52% | 13.91% | 17.41% | 23.76% | 17.97% | 19.07% | 17.20% |
| Operating Income | 70.51B | 64.48B | 58.78B | 49.63B | 52.41B | 46.77B | 44.76B | 36.36B | 34.44B | 30.56B | 29.36B | 30.89B | -678.00M | 24.06B | 29.16B | 27.71B | 45.42B | 34.46B | 29.47B | 23.55B |
| Operating Income Ratio | 18.76% | 18.43% | 17.27% | 14.82% | 16.22% | 17.11% | 16.76% | 14.29% | 13.25% | 12.89% | 13.34% | 15.91% | -0.41% | 12.13% | 11.10% | 13.87% | 21.30% | 14.71% | 16.70% | 14.60% |
| Total Other Income/Expenses | -2.10B | -1.73B | -2.55B | -2.71B | -7.08B | -6.66B | -8.94B | -3.27B | -12.48B | 111.77B | -8.08B | -13.09B | -75.21B | -11.53B | -21.73B | -14.63B | -3.39B | -2.81B | -8.51B | -8.59B |
| Income Before Tax | 68.41B | 62.75B | 56.23B | 46.92B | 45.33B | 40.10B | 35.82B | 33.09B | 21.96B | 142.33B | 21.28B | 17.81B | -75.89B | 12.53B | 7.43B | 13.09B | 42.04B | 31.65B | 20.96B | 14.95B |
| Income Before Tax Ratio | 18.20% | 17.93% | 16.52% | 14.01% | 14.03% | 14.67% | 13.42% | 13.00% | 8.45% | 60.04% | 9.67% | 9.17% | -45.46% | 6.32% | 2.83% | 6.55% | 19.72% | 13.51% | 11.88% | 9.27% |
| Income Tax Expense | 22.57B | 18.67B | 20.30B | 14.08B | 14.50B | 11.95B | 12.25B | 12.63B | 5.06B | 8.97B | 10.69B | 7.26B | -4.51B | 5.94B | 3.22B | 3.05B | 19.75B | 14.36B | 9.27B | 4.76B |
| Net Income | 45.08B | 43.06B | 34.97B | 31.80B | 29.80B | 27.28B | 22.60B | 19.74B | 16.36B | 82.94B | 10.12B | 10.24B | -71.77B | 6.32B | 6.35B | 10.10B | 21.74B | 17.41B | 11.68B | 9.91B |
| Net Income Ratio | 11.99% | 12.31% | 10.27% | 9.49% | 9.22% | 9.98% | 8.46% | 7.76% | 6.29% | 34.99% | 4.60% | 5.28% | -42.99% | 3.19% | 2.42% | 5.06% | 10.20% | 7.43% | 6.62% | 6.14% |
| EPS | 215.82 | 206.15 | 167.35 | 152.11 | 141.58 | 125.79 | 104.17 | 91.00 | 75.91 | 386.24 | 47.10 | 47.58 | -333.34 | 29.34 | 39.02 | 63.98 | 275.44 | 220.40 | 169.24 | 83.28 |
| EPS Diluted | 215.82 | 206.15 | 167.35 | 152.11 | 141.58 | 125.79 | 104.17 | 91.00 | 75.91 | 386.24 | 47.10 | 47.58 | -333.34 | 29.34 | 39.02 | 63.98 | 275.44 | 220.40 | 162.96 | 82.76 |
| Weighted Avg Shares Out | 208.90M | 208.89M | 208.94M | 209.02M | 210.45M | 216.85M | 216.94M | 216.95M | 215.51M | 214.73M | 214.86M | 215.31M | 215.32M | 215.34M | 162.66M | 157.87M | 157.90M | 157.96M | 135.84M | 118.95M |
| Weighted Avg Shares Out (Dil) | 208.90M | 208.89M | 208.94M | 209.02M | 210.45M | 216.85M | 216.94M | 216.95M | 215.51M | 214.73M | 214.86M | 215.31M | 215.32M | 215.34M | 162.66M | 157.87M | 157.90M | 157.96M | 135.84M | 119.70M |
Source: https://incomestatements.info
Category: Stock Reports